Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Protocol ID
ASCT2031
Disease (Sub Disease)
Leukaemia
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Diagnosis Stage
Newly diagnosed
Sponsor
Children's Oncology Group
Links
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 3
Age Eligibility
6 Months to 22 Years
International registry ID's
NCT05457556
| Study Title | A Multi-Center Phase 3 Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children Adolescents and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS) |
|---|---|
| Protocol ID | ASCT2031 |
| Disease (Sub Disease) | Leukaemia Myelodysplastic Syndrome |
| Diagnosis Stage | Newly diagnosed |
| Sponsor | Children's Oncology Group |
| Links | https://clinicaltrials.gov/ct2/show/NCT05457556 |
| Trial Status | Preparing to Open |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | 6 Months to 22 Years |
| International registry ID's | NCT05457556 |